<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00483392</url>
  </required_header>
  <id_info>
    <org_study_id>J3-3545</org_study_id>
    <secondary_id>Slovenia grant J3-3545</secondary_id>
    <nct_id>NCT00483392</nct_id>
  </id_info>
  <brief_title>Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the effects of treatment with
      rosiglitazone and metformin on insulin resistance in patients infected with Human
      Immunodeficiency Virus on stable Highly Active Antiretroviral Therapy including a Protease
      Inhibitor after the period of 48 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fasting plasma glucose, basal insulin levels</measure>
    <time_frame>48 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>insulin resistance, beta cell function</measure>
    <time_frame>48 week</time_frame>
  </secondary_outcome>
  <condition>Insulin Resistance</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin, rosiglitazone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  documented HIV infection

          -  stable Protease Inhibitor containing HAART regimen for at least 12 months

          -  impaired glucose tolerance

          -  elevated insulin levels (above 20 mIU/l)

        Exclusion Criteria:

          -  patients already taking oral hypoglycaemic treatment or insulin

          -  heart failure NYHA I-IV

          -  liver disease or kidney disease

          -  elevated AST or ALT above 2 times upper normal range

          -  elevated creatinine (above 150 mmol/l)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Andrej Janez, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, Medical Center Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Endocrinology, Diabetes and Metabolic diseases</name>
      <address>
        <city>Ljubljana</city>
        <zip>1525</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2007</study_first_submitted>
  <study_first_submitted_qc>June 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2007</study_first_posted>
  <last_update_submitted>June 5, 2007</last_update_submitted>
  <last_update_submitted_qc>June 5, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2007</last_update_posted>
  <keyword>insulin</keyword>
  <keyword>rosiglitazone</keyword>
  <keyword>metformin</keyword>
  <keyword>hiv</keyword>
  <keyword>protease inhibitors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosiglitazone</mesh_term>
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

